Sio Capital Management, LLC
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1482416.
- Reported value$604.3m
- Positions59
Holdings: 59 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Anteris Technologies GlobalAVR | COM | 03675P102 | 54.6 | 9.0% | 5,545,984 | Added+163,019 | |
| Cencora IncCOR | COM | 03073E105 | 49.1 | 8.1% | 173,588 | Added+72,694 | |
| Maximus IncMMS | COM | 577933104 | 38.5 | 6.4% | 715,267 | Reduced−53,558 | |
| Allogene Therapeutics IncALLO | COM | 019770106 | 27.7 | 4.6% | 13,323,431 | New+13,323,431 | |
| Globus Med IncGMED | CL A | 379577208 | 23.8 | 3.9% | 301,816 | New+301,816 | |
| GSK plcGSK | SPONSORED ADR | 37733W204 | 22.9 | 3.8% | 436,700 | Added+50,821 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 22.2 | 3.7% | 695,315 | Added+89,876 | |
| Waystar HLDG CorpWAY | COM | 946784105 | 19.0 | 3.1% | 925,834 | Reduced−716,402 | |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 18.2 | 3.0% | 1,230,700 | Put | New+1,230,700 |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 17.9 | 3.0% | 480,383 | New+480,383 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 16.9 | 2.8% | 177,118 | Added+44,622 | |
| The Cigna GroupCI | COM | 125523100 | 15.9 | 2.6% | 57,750 | New+57,750 | |
| Sanofi SASNY | SPONSORED ADR | 80105N105 | 15.5 | 2.6% | 364,200 | Added+124,529 | |
| Icon Pub Ltd Co | SHS | G4705A100 | 15.3 | 2.5% | 88,186 | Reduced−218,172 | |
| Viatris IncVTRS | COM | 92556V106 | 15.2 | 2.5% | 954,299 | New+954,299 | |
| Cross Ctry Healthcare Inc | COM | 227483104 | 14.5 | 2.4% | 1,098,393 | Unchanged | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 12.8 | 2.1% | 307,657 | Reduced−59,152 | |
| Abbott LaboratoriesABT | COM | 002824100 | 11.7 | 1.9% | 128,656 | Reduced−57,918 | |
| Celcuity IncCELC | COM | 15102K100 | 11.5 | 1.9% | 110,022 | Reduced−83,821 | |
| Zimmer Biomet Holdings IncZBH | COM | 98956P102 | 11.3 | 1.9% | 131,445 | Added+68,832 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 11.2 | 1.9% | 18,000 | New+18,000 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 11.1 | 1.8% | 193,500 | New+193,500 | |
| Medtronic plc | SHS | G5960L103 | 11.1 | 1.8% | 142,500 | New+142,500 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 11.0 | 1.8% | 1,075,274 | Reduced−423,346 | |
| Senseonics Holdings IncSENS | COM | 81727U303 | 9.0 | 1.5% | 1,592,692 | Added+1,476,908 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 8.9 | 1.5% | 623,130 | Reduced−98,655 | |
| Cybin Inc | COM NEW | 23256X407 | 8.6 | 1.4% | 1,300,000 | New+1,300,000 | |
| ANI Pharmaceuticals IncANIP | COM | 00182C103 | 8.1 | 1.3% | 97,305 | Reduced−168,238 | |
| Protara Therapeutics IncTARA | COM STK | 74365U107 | 7.3 | 1.2% | 1,921,872 | Reduced−47,967 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 6.9 | 1.1% | 1,003,562 | Added+38,562 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 6.5 | 1.1% | 208,500 | New+208,500 | |
| Aquestive Therapeutics IncAQST | COM | 03843E104 | 6.2 | 1.0% | 1,486,175 | Reduced−436,712 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 5.8 | 1.0% | 59,254 | Reduced−310,791 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 5.6 | 0.9% | 127,808 | Reduced−166,532 | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 5.3 | 0.9% | 539,493 | Reduced−429,104 | |
| Zenas Biopharma IncZBIO | COM | 98937L105 | 5.3 | 0.9% | 208,557 | Reduced−123,173 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 5.2 | 0.9% | 73,952 | Reduced−12,131 | |
| Onkure Therapeutics IncOKUR | COM CL A | 68277Q105 | 4.9 | 0.8% | 1,078,965 | Unchanged | |
| Savara IncSVRA | COM | 805111101 | 3.8 | 0.6% | 617,675 | Added+3,787 | |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 3.5 | 0.6% | 2,634,137 | Reduced−442,443 | |
| Aveanna Healthcare Holdings IncAVAH | COM | 05356F105 | 3.2 | 0.5% | 369,036 | New+369,036 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 2.7 | 0.4% | 1,005,334 | Reduced−247,047 | |
| Immunome IncIMNM | COM | 45257U108 | 2.6 | 0.4% | 124,168 | Reduced−40,942 | |
| Hims & Hers Health IncHIMS | COM CL A | 433000106 | 2.6 | 0.4% | 75,000 | Call | New+75,000 |
| AN2 Therapeutics IncANTX | COM | 037326105 | 2.6 | 0.4% | 529,933 | Reduced−127,267 | |
| Serina Therapeutics IncSER | COM SHS | 81751A108 | 1.9 | 0.3% | 1,000,000 | Unchanged | |
| Aligos Therapeutics IncALGS | COM NEW | 01626L204 | 1.9 | 0.3% | 327,237 | Unchanged | |
| Ibio IncIBIO | COM NEW | 451033708 | 1.6 | 0.3% | 904,268 | Unchanged | |
| Xilio Therapeutics IncXLO | COM | 98422T209 | 1.5 | 0.2% | 152,464 | Unchanged | |
| Artivion IncAORT | COM | 228903100 | 1.1 | 0.2% | 48,481 | New+48,481 | |
| Bridgebio Oncology TherapeutBBOT | COM NEW | 107924102 | 1.0 | 0.2% | 130,628 | Unchanged | |
| Tela Bio IncTELA | COM | 872381108 | 0.5 | <0.1% | 636,300 | Unchanged | |
| Adagio Med Holdings IncADGM | COM | 00534B100 | 0.5 | <0.1% | 698,989 | Reduced−589,472 | |
| Neuroone Med Technologies CoNMTC | COM | 64130M308 | 0.3 | <0.1% | 82,767 | New+82,767 | |
| Enveric Biosciences IncENVB | COM SHS | 29405E505 | 0.2 | <0.1% | 180,000 | New+180,000 | |
| Modular Med IncMODD | COM NEW | 60785L306 | 0.1 | <0.1% | 26,190 | Unchanged | |
| QT Imaging Holdings IncQTI | COM | 746962307 | 0.1 | <0.1% | 15,236 | New+15,236 | |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | 0.0 | <0.1% | 400,000 | Unchanged | |
| Humacyte Inc | *W EXP 08/27/202 | 44486Q111 | 0.0 | <0.1% | 49,998 | Unchanged |
Sold out: 34 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 0.0 | 0.0% | 0 | Sold out−135,800 | |
| Biohaven Ltd | COM | G1110E107 | 0.0 | 0.0% | 0 | Sold out−1,163,926 | |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 0.0 | 0.0% | 0 | Sold out−194,226 | |
| Boundless Bio IncBOLD | COM | 10170A100 | 0.0 | 0.0% | 0 | Sold out−163,679 | |
| Centene Corp DelCNC | COM | 15135B101 | 0.0 | 0.0% | 0 | Put | Sold out−100,000 |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−1,506,525 | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 0.0 | 0.0% | 0 | Sold out−917,922 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 0.0 | 0.0% | 0 | Sold out−674,759 | |
| Crinetics Pharmaceuticals in | COM | 22663K107 | 0.0 | 0.0% | 0 | Sold out−249,887 | |
| Disc Medicine IncIRON | COM | 254604101 | 0.0 | 0.0% | 0 | Sold out−65,203 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Sold out−268,986 | |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.0 | 0.0% | 0 | Put | Sold out−11,700 |
| Embecta CorpEMBC | COMMON STOCK | 29082K105 | 0.0 | 0.0% | 0 | Sold out−1,847,850 | |
| Enanta Pharmaceuticals IncENTA | COM | 29251M106 | 0.0 | 0.0% | 0 | Sold out−40,000 | |
| Erasca IncERAS | COM | 29479A108 | 0.0 | 0.0% | 0 | Sold out−5,000 | |
| Foghorn Therapeutics IncFHTX | COM | 344174107 | 0.0 | 0.0% | 0 | Sold out−122,889 | |
| Haemonetics Corp MassHAE | COM | 405024100 | 0.0 | 0.0% | 0 | Sold out−220,672 | |
| Hyperfine IncHYPR | COM CL A | 44916K106 | 0.0 | 0.0% | 0 | Sold out−1,000,000 | |
| Integra Lifesciences Holdings CIART | COM NEW | 457985208 | 0.0 | 0.0% | 0 | Sold out−383,140 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 0.0 | 0.0% | 0 | Sold out−32,235 | |
| Livanova plc | SHS | G5509L101 | 0.0 | 0.0% | 0 | Sold out−421,615 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 0.0 | 0.0% | 0 | Sold out−173,506 | |
| Neuroone Med Technologies Co | COM NEW | 64130M209 | 0.0 | 0.0% | 0 | Sold out−496,614 | |
| Nyxoah S a | SHS | B6S7WD106 | 0.0 | 0.0% | 0 | Sold out−50,839 | |
| Organon & CoOGN | COMMON STOCK | 68622V106 | 0.0 | 0.0% | 0 | Sold out−865,908 | |
| Oscar Health IncOSCR | CL A | 687793109 | 0.0 | 0.0% | 0 | Put | Sold out−3,000 |
| Proqr Therapeutics N V | SHS EURO | N71542109 | 0.0 | 0.0% | 0 | Sold out−1,954,715 | |
| Quidelortho CorpQDEL | COM | 219798105 | 0.0 | 0.0% | 0 | Sold out−359,011 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Sold out−720,036 | |
| Shoulder Innovations IncSI | COMMON STOCK | 82537J108 | 0.0 | 0.0% | 0 | Sold out−210,641 | |
| Simulations Plus Inc | COM | 829214105 | 0.0 | 0.0% | 0 | Sold out−200 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.0 | 0.0% | 0 | Sold out−209,093 | |
| Teleflex IncorporatedTFX | COM | 879369106 | 0.0 | 0.0% | 0 | Sold out−94,800 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−10,100 |
Source: SEC EDGAR, Form 13F-HR, accession 0001214659-26-010311 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.